2015 Report on Licensing Terms and Agreements in Pharma, Biotech and Diagnostics

DALLAS, February 16, 2015 /PRNewswire/ --

The Licensing Terms and Agreements in Pharma, Biotech and Diagnostics 2015 report now available with RnRMarketResearch.com provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the world's leading life science companies.

This report contains links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners. The report provides a detailed understand and analysis of how and why Pharma, Biotech and Diagnostics companies enter licensing deals. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not. Complete report is available at http://www.rnrmarketresearch.com/licensing-terms-and-agreements-in-pharma-biotech-and-diagnostics-market-report.html .

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading life science companies worldwide.

The research includes: Trends in licensing dealmaking in the biopharma industry since 2010; Analysis of licensing deal structure; Case studies of real-life licensing deals; Comprehensive listing of licensing deals since 2010; Access to licensing contract documents; Key financial benchmarks for headline, upfront, milestone and royalty rates; The leading licensing deals by value since 2010; Most active licensing dealmakers since 2010 and leading licensing partnering resources.

In Licensing Terms and Agreements in Pharma, Biotech and Diagnostics report, available deals and contracts are listed by: Company A-Z, Headline value, Therapeutic area and Technology type. Each deal title links via Web link to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand. Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=194140 .

This report provides its readers key benefits like in-depth understanding of licensing partnering deal trends since 2010, insight into the terms included in a licensing agreement, together with real world clause examples, identify leading licensing deals by value since 2010, identify the most active licensing dealmakers since 2010, analysis of key deal financials including headline value, upfront, milestone payments and royalty rates, full listing of licensing deals by company A-Z, deal value, phase of development, deal type, therapy and technology focus, comprehensive access to over 4,000 licensing deals entered into by the world's biopharma companies, together with contract documents if available and detailed access to actual licensing contracts entered into by the leading fifty big pharma and big biotech companies. The research also helps understand the key deal terms companies have agreed in previous deals and undertake due diligence to assess suitability of your proposed deal terms for partner companies.

For the Pharma, Biotech and Diagnostics market players, RnRMarketResearch.com also has a report on Co-promotion and Co-marketing Partnering Terms and Agreements, that provides comprehensive understanding and unprecedented access to 700 co-promotion and co-marketing deals and partnering agreements entered into by the world's leading healthcare companies. This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of co-promotion and co-marketing agreements from 2009 to end of December 2014. This revised and updated edition published in 2015 covers trends in co-promotion and co-marketing deals, co-promotion and co-marketing agreement structure, co-promotion and co-marketing contract documents, top co-promotion deals by value, top co-marketing deals by value, most active co-promotion dealmakers and most active co-marketing dealmakers.

Explore more research reports on the healthcare regulation and policy sectors at http://www.rnrmarketresearch.com/reports/life-sciences/healthcare/regulation-policy/regulation .

About Us: 

RnRMarketResearch.com is a database of selected syndicated market research reports for global and regional industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.

Contact:   

Ritesh Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel:  +1-888-391-5441
[email protected]

SOURCE RnR Market Research